Six biomarkers of the model (CYSTM1, PCOLCE2, GLDN, SEZ6L, SDSL, and TNFRSF18) demonstrated the differential expression of COVID‐19′s prognostic and shed light on the clinical biomarkers to apply to patients (Figure S3A and Table S6). This evidence concerns the gene GLDN and COVID-19.